IC

IBS Capital

North America, Massachusetts, United States, Boston

Description

IBS Capital is an advisory and investment management company that provides hedge fund investment services.

Investor Profile

IBS Capital has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series C (25%)
  • Post Ipo Equity (25%)
  • Series A (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Neuroscience
  • Pharmaceutical
  • Commercial
  • Manufacturing
  • Mineral
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IBS Capital frequently co-invest with?

DRADS Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
C
North America, New York, United States, New York
Co-Investments: 1
Lineage Cell Therapeutics
North America, California, United States, Carlsbad
Co-Investments: 1
Spinnaker Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
KIZOO Technology Capital
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Co-Investments: 1
Wexford Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1

Which angels does IBS Capital often collaborate with?

JM
North America, Texas, United States, Dallas
Shared Deals: 1
JM
Europe, Isle of Man
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by IBS Capital?

AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series COct 17, 2019
Amount Raised: $26,300,000
AgeX Therapeutics

Alameda, California, United States

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 2, 2017
Amount Raised: $10,000,000
AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series ANov 20, 2015
Amount Raised: $16,500,000
Applied Minerals

New York, New York, United States

Applied Minerals produces halloysite clay with commercially consistent product grades.

CommercialManufacturingMineral
Post Ipo EquityNov 7, 2014
Amount Raised: $2,000,000